Interaction between natural killer and dendritic cells: The role of CD40, CD80 and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-γ production

Scandinavian Journal of Immunology

Volumn 59, Issue 4, 2004, Pages 356-362

  Terrazzano, G ^a   Pisanti, S ^a   Grimaldi, S ^a   Sica, M ^a   Fontana, S ^b   Carbone, E ^c,d   Zappacosta, S ^a   Ruggiero, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AUTOANTIGEN; B7 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL KILLER CELL RECEPTOR NKG2D;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANTIGENS, CD40; ANTIGENS, CD80; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL;

EID: 1842633584     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2003.01387.x     Document Type: Article

References (56)

1. Kiessling R, Klein E, Wigzell H. Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975;5:112-7.
2. Biron C, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather T. Natural killer cells in antiviral defence: function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
3. Scharton-Kersten TM, Sher A. Role of natural killer cells in innate resistance to protozoan infections. Curr Opin Immunol 1997;9: 44-51.
4. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 1997;15:749-95.
5. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridges innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-76.
6. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983;158:670-89.
7. Scott P, Trinchieri G. The role of natural killer cells in host parasite interactions. Curr Opin Immunol 1995;7:34-40.
8. Moretta A, Bottino C, Vitale M et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1997;14:619-48.
9. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-93.
10. Ljunggren H-G, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-44.
11. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet D. Mouse CD94/NKG2A is a natural killer cell receptor for the non classical major histocompatibility complex (MHC) class I molecule Qa-1. J Exp Med 1998;188:1841-8.
12. Raulet DH. Recognition events that inhibit and activate natural killer cells. Curr Opin Immunol 1996;8:372-7.
13. Leibson PJ. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 1997;6:655-61.
14. Moretta A, Bottino C, Vitale M et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223.
15. Lanier LL, Corliss B, Wu L, Phillips J. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998;8:693-702.
16. Vujanovic NL, Deleo AB, Olszowy RB, Herberman E, Hserodt JC. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine activated killer cells. J Exp Med 1989;169:1373-89.
17. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci USA 1999;96:5640-4.
18. Moretta A, Poggi A, Pende D et al. CD69 mediated pathway of lymphocytes activation: anti-CD69 monoclonal antibodies trigger the cytolitic activity of different lymphoid effector cells with the exception of cytolitic lymphocytes expressing T cell receptor α/β. J Exp Med 1991;174:1393-8.
19. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signalling protein SAP. J Immunol 1999;162:6981-5.
20. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998;188:2083-90.
21. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285:727-9.
22. Mandelboim O, Lieberman N, Lev M et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001;409:1055-60.
23. Vitale M, Falco M, Castriconi R et al. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol 2001;31:233-42.
24. Carbone E, Ruggiero G, Terrazzano G et al. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med 1997;185:2053-60.
25. Martin-Fontecha A, Assarsson E, Carbone E, Kärre K, Ljunggren H-G. Triggering of murine NK cells by CD40 and CD86 (B7-2). J Immunol 1999;162:5910-6.
26. Chambers BJ, Salcedo M, H-G.Ljunggren. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 1996;5:311-7.
27. Geldhof AB, Moserr MM, Lespagnard L, Thielemans K, Baetselier D. Interleukin 12 activated natural killer cells recognize B7 co-stimulatory molecules on tumor cells and autologous dendritic cells. Blood 1998; 91:191-206.
28. Galea-Lauri J, Darling D, Gan S-U et al. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. J Immunol 1999;163:62-70.
29. Terrazzano G, Zanzi D, Palomba C et al. Differential involvement of CD40, CD80 and Major Histocompatibility Complex Class I molecules in cytotoxicity induction and Interferon-γ production by human Natural Killer effectors. J Leuk Biol 2002;72:305-9.
30. Luque I, Reyburn H, Strominger JL. Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells. Hum Immunol 2000;61:721-8.
31. Wilson JL, Char J, Martin-Fonzeca A et al. NK cell triggering by human co-stimulatory molecules CD80 and CD86. J Immunol 1999;163:4207-12.
32. Hunter CA, Ellis-Neyer L, Gabriel KE, Grabstein KH, Linsley PS, Remingtron JS. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. J Immunol 1997;158:2285-93.
33. Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J. Co-stimulatory signals are required for optimal proliferation of human natural killer cells. J Immunol 1993;150:1705-10.
34. Nandi D, Gross JA, Allison JP. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J Immunol 1994;152:3361-9.
35. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austin JM. Dendritic cell loss from non lymphoid tissues after systemic administration of lipopolysaccharide, Tumor Necrosis Factor and interleukin 1. J Exp Med 1995;181:2237-41.
36. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cell use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
37. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-82.
38. Young JW, Kovlava L, Soergel SA, Clark EA, Steinman RM, Dupont B. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest 1992;90:229-37.
39. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195:343-9.
40. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003;33:1657-66.
41. Carbone E, Terrazzano G, Ruggiero G et al. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 1999;29:4022-9.
42. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002;195:327-33.
43. Fernadez NC, Flament C, Crepineau F, Angevin E, Vivier E, Zitvogel L. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cross talk. Eur Cytokine Netw 2002;13:17-21.
44. Grewal IS, Flavell RA. CD40 and CD154 in cell mediated immunity. Annu Rev Immunol 1998;16:111-35.
45. Carbone E, Terrazzano G, Melian A et al. NK cell mediated recognition of CD1 molecules and mycobacterium derived lipid antigens presented by CD1b. J Immunol 2000;164:6130-7.
46. Fernandez NC, Lozier A, Flamet C et al. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1998;5:405-11.
47. Sallusto F, Lanzavecchia A. Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/ Macrophage Colony-stimulating Factor plus Interleukin-4 and Downregulated by Tumor Necrosis Factor-α. J Exp Med 1994; 179:1109-13.
48. Moretta A, Vitale M, Sivori S et al. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994;180:545-55.
49. Chambers CA. The expanding world of costimulation: the two signal model revisited. Trends Immunol 2001;22:217-21.
50. Hollenbaugh D, Mischel-Petty N, Edwards CP et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995;182:33-9.
51. Thomas WD, Smith MJ, Si Z, Hersey P. Expression of the co-stimulatory molecule CD40 on melanoma cells. Int J Cancer 1996;68:795-801.
52. Kubota A, Lian RH, Lohwasser S, Salcedo M, Takei F. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC-I molecules. J Immunol 1999;163:6488-93.
53. + NK cells by HLA-B7 variants and target cells. J Immunol 1998;160:1573-80.
54. Carson WE, Lindemann MJ, Baiocchi R et al. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 1995;85:3577-85.
55. Morel AS, Quantino S, Dovek DC, Londei M. Split activity of IL-10 on antigen capture and antigen presentation by human dendritic cells: definition of a mature step. Eur J Immunol 1997;27:26-9.
56. Bancherau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.